Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitrous Oxide for Major Depressive Disorder
NCT03869736Phase 2Completed
- Start
- Jan 2019
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of nitrous oxide in major depressive disorder (MDD). Started Jan 2019; status: completed.
02
Drugs
nitrous oxide
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03869736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03869736.